why choose us

First received: April 03, 2023

Clinical Trial: Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Aplastic Anemia

Study Type: INTERVENTIONAL


Official Title: Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia

Brief Summary: This is a phase 1, prospective, single-arm, open-label study.The aim of this study is to evaluate the transfusion responses of platelet increment by using Daratumumab among aplastic anemia patients with platelet transfusion refractoriness.

Read more